DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Keywords: monte carlo
| MO-EF-TRACK 4-10 | Tumor Dosimetry and Radiobiological Modeling of Combined Radiopharmaceutical Therapy and External Beam Radiotherapy for Recurrent Head and Neck Cancer D Adam*, I Marsh, J Grudzinski, T Bradshaw, P Hill, S Cho, C Hullett, A Burr, P Harari, B Bednarz, University of Wisconsin, Madison, WI |
| MO-IePD-TRACK 1-6 | Implementation of Detailed Monte Carlo Simulation for Semiconductor Detectors Using the PENELOPE Code H Mendes*, A Tomal, University Of Campinas |
| PO-GePV-E-15 | VICTORIA: Online Monte Carlo and DICOM Data Viewer E Badun1*, F Tessier2, R Townson2, M Bazalova-Carter1, (1) University of Victoria, Victoria, BC, CA, (2) National Research Council Canada, Ottawa, ON, CA |
| PO-GePV-I-20 | TOPAS for Imaging: A Monte Carlo Simulation Tool for PET/SPECT/CBCT Imaging J Feld1*, C Zhang2, G Cojocaru3, S Longawa4, H Paganetti5, J Schuemann6, (1) Mass General Hospital and Massachusetts Institute of Technology, ,,(2) Mass General Hospital And Boston University, ,,(3) Mass General Hospital And Massachusetts Institute Of Technology, ,,(4) Mass General Hospital And Massachusetts Institute Of Technology, ,,(5) Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA, Boston, MA, (6) Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA, Boston, MA |
| PO-GePV-M-86 | Comparison of Online Adaptation and Offline Re-Planning for Head and Neck Intensity-Modulated Proton Therapy M Bobic1,2*, A Lalonde1, K Nesteruk1, H Lee1, J Verburg1, G Sharp1, B Winey1, A Lomax2,3, H Paganetti1, (1) Massachusetts General Hospital and Harvard Medical School, Boston, MA, (2) ETH Zurich, Zurich, CH, (3) Paul Scherrer Institute, Villigen, CH |
| PO-GePV-M-158 | Enhancing Cherenkov Photon Yield by Gold Implants K Okazaki1*, E Brost2, Y Watanabe1, (1) University of Minnesota, Minneapolis, MN, (2) Mayo Clinic, Rochester, MN, |
| PO-GePV-M-209 | Analysis of the Dose Enhancement Factor in the Presence of Gold Nanoparticles in Clinical Radiotherapy Beams P Monteiro1*, A Quevedo2, H Trombini1, T Pianoschi 1, (1)Federal University of Health Sciences of Porto Alegre ,Porto Alegre, RS, BR, (2) University of Sao Paulo, Ribeirao Preto, SP, BR |
| PO-GePV-T-20 | Evaluation of Dosimetric Parameters of Two Brachytherapy Ophthalmic Sources Using Monte Carlo Simulation P Ramon1*, A Quevedo2, T Pianoschi 3, (1) Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, BR, (2) University of Sao Paulo, Ribeirao Preto, SP, BR, (3) Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, BR |
| PO-GePV-T-25 | Evaluation of Dose Distribution From An Ophthalmic Brachytherapy Through the TOPAS Code I Knoll1*, L de Souza2, A Quevedo3, M Alva4, (1) ,Porto Alegre, RS, BR, (2) ,Porto Alegre, RS, BR, (3) University of Sao Paulo, Ribeirao Preto, SP, BR, (4) Universidade Federal de Ciencias da Saude de Porto Alegre, Porto Alegre, RS, BR |
| PO-GePV-T-35 | Calculation of Stopping-Power Ratios for Electron Beams Used in Total Skin Electron Therapy G Ding*, Vanderbilt University, Nashville, TN |
| PO-GePV-T-44 | Bremsstrahlung Dose of the Electron Beam at Extended Distances Used in Total Skin Electron Therapy G Ding1*, S Kucuker Dogan2, I Das3, (1) Vanderbilt University, Nashville, TN, (2) Northwestern Memorial Hospital, Chicago, IL, (3) Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL |
| PO-GePV-T-53 | A Comparative Study of Different Collimation Methods for Quantification of Required Skin Margin During electron Treatment N Shrestha1*, M Brenner2, G Narayanasamy1, S Morrill1, Z Su1, G Lewis1, F Kalantari1, (1) Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, (2) Department of Radiation Oncology, Mercy Health System, Rockford, IL |
| PO-GePV-T-72 | Developing a Workflow Using Supercomputer Accelerated Monte Carlo Simulation Based On Machine Log-Files for Patient Specific Quality Assurance of the Mevion S250i Proton Therapy System B Chiang*, Y Chen, S Ahmad, University of Oklahoma Health Sciences Center, Oklahoma City, OK |
| PO-GePV-T-73 | Analysis of the Difference in Calculation of Physical Dose for Each Patient Site of SECT and DECT Using TOPAS E Yoon*, S Jung, J Son, B Kim, C Choi, J Kim, J Park, Seoul National University Hospital, Seoul, 11KR, |
| PO-GePV-T-77 | Virtual Particle Monte Carlo (VPMC), a New Concept to Avoid Simulating Secondary Particles in Proton Therapy Dose Calculation J Shan*, M Fatyga, W Liu, Mayo Clinic Arizona, Phoenix, AZ |
| PO-GePV-T-79 | Development of a Fast and Memory-Efficient Monte Carlo Code for Proton Dose Calculation H Lee*, J Shin, J Verburg, H Paganetti, Massachusetts General Hospital, Boston, MA |
| PO-GePV-T-90 | Influence of Beam Quality Correction Factors On Measurement Depth in Scanning Proton Beams Using Monte Carlo Calculation M Ichihara1*, K Yasui2, C Omachi3, T Toshito3, J Nagata1, R Oshika1, S Kurata1, N Hayashi2,(1) Graduate school of Health Sciences, Fujita Health University, Toyoake, Aichi, JP, (2) School of Medical Science, Fujita Health University, Tayoake, Aichi, JP, (3)Nagoya Proton Therapy Center, Nagoya, Aichi, JP |
| PO-GePV-T-168 | 4D Monte Carlo Assessment of the Impact of Inter- and Intra-Fractional Respiratory Motion Variation On Delivered Dose M Shiha1,2*, J E Cygler1,2,3, R Macrae1,3, E Heath2 (1) The Ottawa Hospital Cancer Centre, Ottawa, ON, CA, (2) Carleton Univ, Ottawa, ON, CA,(3) University of Ottawa, Ottawa, ON, CA |
| PO-GePV-T-216 | Dosimetric Impact in GNP-Enhanced Radiotherapy Using the 10 MV FF and FFF Photon Beams: A Monte Carlo Depth Dose Study J Chow1*, (1) Princess Margaret Cancer Centre, Toronto, ON, CA |
| PO-GePV-T-217 | A Study of Surface Dosimetry for Whole Breast Irradiation Geometry Using EBT3 Gafchromic Film and Monte Carlo Simulation S Su1*, E Carpentier2, C Duzenli1,2, (1) British Columbia Cancer Agency, Vancouver, BC, CA, (2) University of British Columbia, Vancouver, BC, CA |
| PO-GePV-T-219 | Feasibility of 18-MV Grid Therapy From the View of Radiation Protection AH Karimi1, X Wang2*, SF Mirian3, HR Vega-Carrillo4, M Mohiuddin2, (1) Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., (2) Advocate Aurora Health, Park Ridge, IL, (3) Department Of Nuclear Engineering, University Of Isfahan, Isfahan, Iran,(4) University Autonomous of Zacatecas, Zacatecas, Zac, Mexico |
| PO-GePV-T-220 | Impact of Depth-Induced Spectrum Change On the Dose Enhancement of Gold Nanoparticle Aided Radiotherapy at Megavoltage Energy R Schmidt*, J Shi, J Ford, D Hara, N Dogan, A Pollack, University of Miami, Miami, FL |
| PO-GePV-T-221 | Validation of the Monte Carlo Model of a Novel Biology-Guided Radiotherapy (BgRT) Linac M Shi1*, K Bush1, C Chuang1, D Zaks2, L Xing1, N Kovalchuk3, M Surucu4, B Han4, (1) Stanford University, Stanford, CA, (2) RefleXion Medical, Hayward, CA, (3) Stanford University Cancer Center, Palo Alto, CA, (4) Stanford University School of Medicine, Stanford, CA |
| PO-GePV-T-222 | Focal Spot Size Effect of the RefleXion X1 Radiotherapy Machine: A Monte Carlo Simulation Study OM Oderinde*, D Zaks, C Huntzinger, SM Shirvani, T Laurence, M Lu, RefleXion Medical, Hayward, CA |
| PO-GePV-T-224 | On the Determination of Source Parameter Probability Distribution Functions During the Monte Carlo Modeling of a CyberKnife M6 Unit J Duchaine*1,2, D Markel3, H Bouchard1,2,3, (1) Université de Montréal, Montréal, QC, CA, (2) Centre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, CA, (3) Centre Hospitalier de l'Université de Montréal, Montréal, QC, CA |
| PO-GePV-T-225 | KQ Calculations of the ZAP-X Radiosurgical Device R Townson1*, F Tessier1, G Weidlich2, D Pang3, M McEwen1, (1) National Research Council Canada, Ottawa, ON, CA, (2) ZAP Surgical Systems, San Carlos, CA, (3) Georgetown University Hospital, Washington, DC |
| PO-GePV-T-279 | PenMRT: A Multi-Scale Dose Calculation Engine for Microbeam Radiation Therapy S KESHMIRI*, S Brocard, N Rosuel, R Serduc, J Adam, INSERM UA 7 STROBE, Grenoble, France |
| PO-GePV-T-322 | Treatment Planning and Verification for Radiodynamic Therapy Using 45 MV Beams A Eldib*, J Liu, C Ma, Fox Chase Cancer Center, Philadelphia, PA |
| PO-GePV-T-365 | Evaluation of Model-Based Dose Algorithms Using HU as a Density Surrogate for FFF-SBRT of Island Lung Lesions B Bismack*, S Devpura, I Chetty, Henry Ford Health System, Detroit, MI |
| PO-GePV-T-371 | Use Monte-Carlo Simulation to Determine the Coverage-Based PTV Margin L Huang*, J Chang, Northwell Health, Lake Success, NY |
| PO-GePV-T-405 | Comparison of Ray Tracing and Monte Carlo Algorithms for Spine Lesions Treated with CyberKnife J Li*, X Zhang, Y Pan, H Zhuang, R Yang, |
| SU-E-TRACK 5-2 | A GPU-Accelerated Monte Carlo Engine for Calculation of MLC-Collimated Electron Fields E Brost*, H Wan Chan Tseung, J Antolak, Department of Radiation Oncology, Mayo Clinic, Rochester, MN |
| SU-F-TRACK 3-7 | Automating Tumor Functional Diameter Measurement with Molecular Breast Imaging for Treatment Response Assessment BP Lopez*, GM Rauch, SC Kappadath, UT MD Anderson Cancer Center, Houston, TX |
| SU-F-TRACK 5-7 | Development of a Framework to Assess Robustness of Dynamic Trajectory Treatment Plans H A Loebner1*, W Volken1, S Mueller1, J Bertholet1, P-H Mackeprang1, G Guyer1, D M Aebersold1, M F M Stampanoni2, P Manser1, M K Fix1, (1) Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland, (2) Institute for Biomedical Engineering, ETH Zuerich and PSI, Villigen, Switzerland |
| SU-IePD-TRACK 2-4 | Monte-Carlo Simulation of the Detective Quantum Efficiency of Cadmium Telluride X-Ray Detectors for Photon-Counting Mammography J Day*, J Tanguay, Ryerson University, Toronto, ONCA, |
| SU-IePD-TRACK 5-3 | Development of a Dynamic-Shield Applicator Enabling Intensity-Modulated Brachytherapy for the Treatment of Rectal Cancer A Thibodeau-Antonacci1*, T Vuong2, H Bekerat1,2, L Liang1,2, S Abbasinejad Enger1,3, (1) McGill University, Montreal, QC, CA, (2) Jewish General Hospital, Montreal , QC, CA, (3) Lady Davis Institute, Montreal, Qc, CA. |
| SU-IePD-TRACK 6-1 | Monte Carlo Characterization of High Atomic Number Inorganic Scintillators for in Vivo Dosimetry in Ir-192 Brachytherapy V Kaveckyte1,2*, E B Joergensen3,4, J G Johansen4, A Carlsson Tedgren1,2 (1) Department of Health, Medicine and Caring Sciences, Linkoping University, SE-58185 Linkoping, Sweden (2) Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, SE-17176 Stockholm, Sweden (3) Aarhus University, Health Graduate School, DK-8000 Aarhus, Denmark (4) Department of Oncology, Aarhus University Hospital, DK-8200 Aarhus, Denmark |
| SU-IePD-TRACK 6-1 | Monte Carlo (MC) Simulation of Total Skin Electron Therapy (TSET) with TOPAS and EGSnrc W Zhong1*, G Ding2, Y Ong1, T Zhu1, (1) University of Pennsylvania, Philadelphia, PA, (2) Vanderbilt University, Nashville, TN |
| SU-IePD-TRACK 6-4 | A Monte Carlo Characterization of Positional Accuracy of a Double-Focused and Double-Stack Multileaf Collimator On a 0.35 T MR-Linac A Khan1*, E Simiele2, L DeWerd1, P Yadav3, (1) Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, (2) Department of Radiation Oncology, Stanford University School of Medicine, (3) Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, |
| SU-IePD-TRACK 6-6 | Monte Carlo Simulation of the Permanent Implant - GammaTile B Rogers*, C Ferreira, University of Minnesota - Twin Cities, Minneapolis, MN |
| TH-C-TRACK 5-3 | Influence of the Freedom in Table Rotation On Plan Quality, Deliverability, Delivery Time and Robustness of Dynamic Trajectory Treatment Plans H A Loebner1*, S Mueller1, W Volken1, G Guyer1, P Wallimann1, D M Aebersold1, M F M Stampanoni2, M K Fix1, P Manser1, (1) Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland CH, (2) Institute for Biomedical Engineering, ETH Zuerich and PSI, Villigen, Switzerland CH |
| TH-D-TRACK 5-6 | Effect of Incoming Particle Energy and Ionization Cluster Size On the G-Value of Hydrated Electrons A Bui*1, L Childress2, J Sankey2, J Seuntjens13, S A Enger134(1) Medical Physics Unit, McGill University, Montreal, QC, CA, (2) Department of Physics, McGill University, Montreal, QC, CA (3) Research Institute of the McGill University Health Centre, Montreal, QC, CA, (4) Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, CA |
| TH-E-TRACK 5-1 | A Feasibility Study for Deep Learning-Based Efficient Monte Carlo Dose Calculation Method in Radiotherapy X Lu1*, Y Li2, Q Mengke1, L Zhou1, T Song1, (1)Department of Biomedical Engineering, Southern Medical University, Guangzhou, Guangdong, CN, (2)Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, CN |
| TH-E-TRACK 5-2 | A Generative Adversarial Network (GAN) Based Monte Carlo Model for a Biology-Guided Radiation Therapy Machine M Shi1*, S Cui1, D Zaks2, B Han3, (1) Stanford University, Palo Alto, CA, (2) RefleXion Medical, Hayward, ,(3) Stanford University School of Medicine, Stanford, CA |
| TH-E-TRACK 5-3 | Development of a Virtual Source Model for Monte Carlo Based Independent Dose Calculation for Varian Linac J Castle1*, X Feng1, Q Chen2, (1) Carina Medical LLC, Lexington, KY,(2) University of Kentucky, Lexington, KY |
| TH-E-TRACK 5-4 | Microdosimetry of Radionuclides Using Geant4 Simulation Considering the Auger Electron Contribution O Kwon*, D Adam, B Bednarz, University of Wisconsin, Madison, WI |
| TH-E-TRACK 5-7 | Generation of 3D Dosimetric Reference Datasets Using Model-Based Dose Calculations for COMS Eye Plaque Brachytherapy E Fletcher1*, F Ballester2, L Beaulieu3, Y Ma3, H Morrison4, M Rivard5, R Sloboda6, J Vijande2, R Thomson1, (1) Carleton University, Ottawa, ON, CA, (2) University of Valencia (UV-IFIC-IRIMED), Burjassot, ES, (3) CHU de Quebec - Universite Laval, Quebec, QC, CA, (4) Tom Baker Cancer Centre, Calgary, AB, CA, (5) Rhode Island Hospital / Brown University, Providence, RI, USA, (6) Cross Cancer Institute, Edmonton, AB |
| TH-F-TRACK 3-1 | A Dosimetric Evaluation of 223Ra-Dichloride Using a Realistic Model of the Metastatic Castrate-Resistant Prostate Cancer Microenvironment and Whole-Body Pharmacokinetics A Strunets*, D Adam, J Jeffery, B Bednarz, University of Wisconsin, Madison, WI |
| TH-IePD-TRACK 5-5 | Validation of a Full Monte-Carlo Beam Source On the Varian TrueBeam for Primary Standards Establishment in Dose Area Product (DAP) J JURCZAK*, B Rapp, J Gouriou, Universite Paris-Saclay, CEA, List, Laboratoire National Henri Becquerel (LNE-LNHB), F-91120 Palaiseau, France |
| TH-IePD-TRACK 5-7 | Monte Carlo Calculations of Photon Shielding Properties for Commercial Blocks M Kaluarachchi*, E Klein, M Rivard, Rhode Island Hospital / Warren Alpert Medical School Brown University, Providence, RI |
| TU-B-TRACK 6-2 | Model-Based Reconstruction for Proton CT Detected with Multiple-Layer Ionization Chamber X Chen*, B Sun, Y Hao, F Reynoso, A Darafsheh, D Yang, T Zhang, T Zhao, Washington University School of Medicine, St. Louis, MO |
| TU-C-TRACK 6-3 | Features Of TOPAS-NBio – Release 1.0 J Schuemann1*, A McNamara1, J Ramos-Mendez2, N Dominguez-Kondo3, J Perl4, D Yoo1, N Henthron5, J Warmenhoven5, S Ingram5, M Merchant5, K Kirkby5, K Held1, J Laverne5, H Paganetti1, B Faddegon2, (1) Physics Division, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA, Boston, MA, (2) University of California San Francisco, San Francisco, CA, (3) Benemerita Universidad Autonoma de Puebla, Puebla, Mexico, (4) Stanford Linear Accelerator Center, Menlo Park, CA, (5) Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom, GB, (6) The University of Notre Dame, Notre Dame, IN |
| TU-D-TRACK 6-2 | Modeling DNA Structure with Different Chromatin Compaction in TOPAS-NBio Using Hi-C Representations D Yoo1*, N Henthron2, S Ingram2, M Merchant2, K Kirkby2, J Warmenhoven2, A McNamara1, K Held1, H Paganetti1, J Schuemann1, (1) Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA (2) Division Of Cancer Sciences, Faculty Of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom |
| TU-E-TRACK 5-2 | Analysis of Proton Inter-Track Interactions at Ultra-High Dose Rates S Thompson*, K Prise, S McMahon, Queen's University Belfast, Belfast, GB |
| TU-E-TRACK 5-6 | TOPAS-NBio Simulation of Radiation Chemistry Following FLASH Irradiation Including Reactions of Biological Importance M Grochowska1*, A Rucinski2, R Schulte3, J Ramos-Mendez4, (1) University of Warsaw, Warsaw, ,PL, (2) Institute of Nuclear Physics PAN, Krakow, ,PL, (3) Loma Linda University, Loma Linda, CA, (4) University of California San Francisco, San Francisco, CA |
| TU-IePD-TRACK 5-4 | A Novel Component Method to Delineate Surgical Spine Implants for Proton Monte Carlo Dose Calculation C Chang1, S Charyyev2, J Harms3, R Slopsema4, J Wolf5, D Refai6, T Yoon7, M McDonald8, J Bradley9, S Leng10, J Zhou11, X Yang12, L Lin13*, (1) Emory University, Alpharetta, GA, (2) Emory University, Atlanta, GA, (3) Emory University, Atlanta, GA, (4) Emory University, Atlanta, GA, (5) Emory University, Atlanta, GA, (6) Emory University, Atlanta, GA, (7) Emory University, Atlanta, GA, (8)Emory University, Atlanta, GA, (9) Emory University School Of Medicine, ,,(10) Mayo Clinic, Rochester, MN, (11) Emory University, Atlanta, GA, (12) Emory University, Atlanta, GA, (13) Emory University, Atlanta, GA |
| WE-A-TRACK 6-3 | Robust Optimization of Proton Therapy Treatments Using a Variable Range Uncertainty M Cohilis1*, E Sterpin1,2, C Chang3, S Rivas1, L Lin4, J Lee1, K Souris1, (1) UCLouvain, Brussels, BE, (2) KU Leuven, Leuven, BE (3) Emory University, Alpharetta, GA (4) Emory Proton Therapy Center, Atlanta, GA |
| WE-C-TRACK 3-4 | Monte Carlo Dose Calculations for Patient-Specific QA Based On Machine Log Files H Parenica1*, C Kabat1, P Papaconstadopoulos2, N Kirby1, P Myers1, T Wagner1, N Papanikolaou1, S Stathakis1, (1) UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, (2) The Netherlands Cancer Institute, Amsterdam, Netherlands |
| WE-D-TRACK 3-4 | Fast Monte Carlo Simulation of Non-Isotropic X-Ray Source for CT Dose Calculation S Wang1*, A Imran1, D Pal2, E Zucker1, A Wang1, (1) Stanford University, Stanford, CA, (2) GE Healthcare, Menlo Park, CA |
| WE-IePD-TRACK 1-3 | Correcting Cone-Beam CT for Patient-Generated Scatter Using Bayesian Monte Carlo Extrapolation S Blake*, O Dillon, R O'Brien, ACRF Image-X Institute, University of Sydney, Sydney, NSW, AU |
| WE-IePD-TRACK 1-5 | Towards Megavoltage Cone Beam CT (CBCT) with Image Quality of Kilovoltage CBCT J O'Connell*, C Lindsay, M Bazalova-Carter, University of Victoria, BC, Canada |
| WE-IePD-TRACK 4-2 | A Scatter-Rejection Method for Proton Computed Tomography J Houri1*, A Kapadia2,3, (1) Duke University Medical Physics Graduate Program, Durham, NC, (2) Oak Ridge National Laboratory, Oak Ridge, TN, (3) Duke University Medical Center, Durham, NC |
| WE-IePD-TRACK 4-4 | Assessment of Clinical to High Energy Proton Radiography Viability Using TOPAS B Broder1*, M Freeman2, (1) University of Chicago, Chicago, IL, (2) Los Alamos National Laboratory, Los Alamos, NM |
| WE-IePD-TRACK 5-1 | Development and Validation of a TOPAS Monte Carlo Model of a Dynamic Collimation System for Pencil Beam Scanning Proton Therapy N Nelson1*, W Culberson1, D Hyer2, T Geoghegan2, K Patwardhan2, B Smith2, R Flynn2, J Yu3, S Rana3, A Gutierrez3, P Hill4, (1) University of Wisconsin-Madison, School of Medicine and Public Health, Department of Medical Physics, Madison, WI, (2) University of Iowa, Department of Radiation Oncology, Iowa City, IA, (3) Miami Cancer Institute, Department of Radiation Oncology, Miami, FL, (4) University of Wisconsin-Madison, School of Medicine and Public Health, Department of Human Oncology, Madison, WI, USA |
| WE-IePD-TRACK 5-4 | A Mechanistic Model for the Calculation of Oxygen Dependent DNA Damage After Radiation Exposure H Zhu1*, J Li2, X Deng1, R Qiu2, Z Wu2, H Zhang2, (1) Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Gangzhou, Guangdong, CN, (2) Department of Engineering Physics, Tsinghua University, Beijing, CN, |
| WE-IePD-TRACK 5-7 | Validation of Monte Carlo Simulated Tc-99m Absorbed-Dose-To-Water Inside a Custom SPECT/CT Phantom Using Active and Passive Dosimeters: A Novel Approach to Benchmarking Monte Carlo Methods for Targeted Radionuclide Therapy Dosimetry A Bertinetti1*, M Rodrigues2, B Palmer1, C Hammer1, J Hull1, H Vija2, W Culberson1, (1) University of Wisconsin-Madison, Madison, WI, (2) Siemens Healthineers |
| WE-IePD-TRACK 6-6 | Towards the Biological Meaning of the Site in Microdosimetry: Relation to DNA Compactness A Bertolet1*, J Ramos-Mendez2, H Paganetti1, J Schuemann1, (1) Mass General Hospital and Harvard Medical School, Boston, MA, (2) University of California San Francisco, San Francisco, CA |